01858 CHUNLI MEDICAL
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 5.20X | Oper Margin | 16.5% |
|---|---|---|---|
| LT Debt/Equity | 0.0% | Net Margin | 15.5% |
| Total Debt/Equity | 0.0% | Return on Equity | 4.4% |
| Price/Book | 1.93X | Return on Assets | 3.6% |
| (HKD 15.110) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 132.92 | 306.22 | 345.01 | 394.28 | 336.31 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -56.6 | -11.3 | -12.5 | +17.2 | +27.1 |
| Earnings Per Share (HKD) | 0.347 | 0.798 | 0.9 | 1.14 | 0.972 |
| Earnings Per Share Growth (%) | -56.6 | -11.3 | -21.1 | +17.2 | +27.9 |
| Dividend Per Share (HKD) | 0.145 | 0.397 | 0.342 | 0.153 | No dividend |
| P/E* (X) | 43.61 | 18.93 | 16.80 | 13.25 | 15.54 |
| Yield (%) | 0.96 | 2.63 | 2.26 | 1.01 | N/A |
| Dividend Share (%) | 41.88 | 49.73 | 38.01 | 13.39 | N/A |
| Book NAV (HKD) | 7.836 | 8.269 | 7.935 | 7.859 | 3.705 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-12-15 21:40:20
Latest Result
| (RMBMn) | 2025-09 | 2024-09 | Chg* (%) | 2023-09 |
| Cover Period (mths) | 9 | 9 | NA | 9 |
|---|---|---|---|---|
| Turnover | 756.094 | 508.284 | +48.8 | 792.156 |
| Operating Result | 211.724 | 65.411 | +223.7 | 195.934 |
| Profit Before Taxation | 211.789 | 66.165 | +220.1 | 195.883 |
| Taxation | 20.176 | 5.156 | +291.3 | 15.403 |
| Profit /( Loss) After Taxation | 191.613 | 61.009 | +214.1 | 180.48 |
| Minority Interests | 0.081 | -0.143 | -156.6 | -0.142 |
| Net Profit | 191.531 | 61.151 | +213.2 | 180.623 |
| Earnings Per Share () | 0.5463 | 0.1772 | +208.3 | 0.5041 |
| Dividend Per Share () | 0.2304 | 0.0000 | N/A | 0.0000 |
| Announcement Date | 2025-10-30 | 2024-10-30 | NA | 2023-10-30 |
* Annualised
Last Update Time: 2025-12-15 21:40:25
